Literature DB >> 14986767

The CIOMS view on the use of placebo in clinical trials.

Juhana E Idänpään-Heikkilä1, Sev Fluss.   

Abstract

Based on worldwide consultations with experts in science and ethics the revised CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects provide guidance on when the use of placebo as a comparator in clinical research is ethically acceptable. The article reviews the main points of the CIOMS Guidelines and commentaries including the use of placebo in situations where the best current method is available and the relation of placebo to established effective intervention. It discusses the use of placebo in externally sponsored research in low-resource countries and requirements for informed consent related to placebo studies.

Entities:  

Keywords:  Biomedical and Behavioral Research

Mesh:

Substances:

Year:  2004        PMID: 14986767     DOI: 10.1007/s11948-004-0058-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  3 in total

1.  The ethics of placebo-controlled trials--a middle ground.

Authors:  E J Emanuel; F G Miller
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Ethical principles for the guidance of physicians in medical research--the Declaration of Helsinki.

Authors:  J E Idänpään-Heikkilä
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

3.  Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues.

Authors:  R Temple; S S Ellenberg
Journal:  Ann Intern Med       Date:  2000-09-19       Impact factor: 25.391

  3 in total
  2 in total

1.  Placebos and the UK Medical Research Council--and the consumer perspective.

Authors:  Joan E Box
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

Review 2.  Placebo: its action and place in health research today--summary and conclusions.

Authors:  Raymond E Spier
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.